Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Combination Chemotherapy in Advanced Adrenocortical Carcinoma

(2012) Martin Fassnacht et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of Lymphadenectomy on the Oncologic Outcome of Patients With Adrenocortical Carcinoma

(2011) Joachim Reibetanz et al.   ANNALS OF SURGERY

Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas

(2011) Montserrat Ayala-Ramirez et al.   CANCER

Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma

(2011) Matthias Kroiss et al.   CLINICAL ENDOCRINOLOGY

Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

(2011) Graeme Eisenhofer et al.   EUROPEAN JOURNAL OF CANCER

Mitotane has a strong and a durable inducing effect on CYP3A4 activity

(2011) Nielka P van Erp et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study

(2011) Ilse G. Hermsen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors

(2011) Wiebke Arlt et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adrenocortical carcinoma: effect of hospital volume on patient outcome

(2011) Celestino Pio Lombardi et al.   LANGENBECKS ARCHIVES OF SURGERY

Adrenocortical carcinoma: a clinician's update

(2011) Martin Fassnacht et al.   Nature Reviews Endocrinology

Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer

(2010) Francesco Porpiglia et al.   EUROPEAN UROLOGY

High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal Tumors

(2010) Silviu Sbiera et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators

(2010) Montserrat Ayala-Ramirez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adjuvant Therapy in Patients With Adrenocortical Carcinoma: A Position of an International Panel

(2010) Alfredo Berruti et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathogenesis of adrenocortical cancer

(2009) Jérôme Bertherat et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Radiotherapy in adrenocortical carcinoma

(2009) Buelent Polat et al.   CANCER

Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma

(2009) Sara Gonias et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival

(2009) Aurélien de Reyniès et al.   JOURNAL OF CLINICAL ONCOLOGY

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma

(2008) Martin Fassnacht et al.   CANCER